Article

Iridex, Peregrine enter agreement

Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. to become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain.

Mountain View, CA-Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. Under the agreement, Iridex will become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain for the manufacture of certain Iridex products.

“Peregrine is an ideal partner to assist Iridex in not only broadening our channel offering and driving costs out of our supply chain, but we anticipate our partnership will also accelerate product development cycles for new disposable products,” said Will Moore, president and chief executive officer of Iridex.

The arrangement involves Iridex assuming management of Peregrine Surgical’s independent distribution channel in the United States. The integration should provide additional coverage and leverage for both company’s product lines, according to the company.

“Peregrine Surgical has invested in establishing high-quality and efficient manufacturing of surgical instruments,” stated Todd Richmond, president of Peregrine Surgical. “The global reach of Iridex will represent a mutually beneficial partnering for the brand names of both companies.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.